Recent evidence suggests that dressings containing silver oxysalts, that is silver in its most active state (Ag+, Ag2+, Ag3+), are more efficient at killing bacteria than dressings containing commercially available silver(Ag+), thereby making them more cost efficient as fewer dressings are required to eliminate infection. This UK product evaluation which sought to determine the effectiveness of a novel dressing, KerraContactTM Ag with Ag Oxysalt technology, on infected leg ulcers. Method: Patients with infected leg ulceration were recruited from 10 tissue viability clinics across the UK. Parameters evaluated included clinical signs and symptoms of infection  — pain, exudate, odour and swelling/heat/redness. Background information and patient experience were also recorded. Results: Thirty-one patients were included. Pain levels reduced significantly or completely in 43% of patients; exudate levels reduced in 83%; wound odour reduced in 77%; swelling/heat/redness reduced in 75%. Two wounds (9.5%) healed by week four; the remaining 90% (n=19) had improved. Conclusion: The KerraContact Ag dressings had high levels of acceptability by the clinicians and patients who participated in the evaluation and could be to be an effective dressing of choice for managing infected chronic leg ulceration.